18 May 2015 05:21
Biopharmaceutical group Circassia Pharmaceuticals has announced it will make a £139m cash bid for Swedish group Aerocrine. The London-listed company said the offer for Aerocrine, a developer of medical diagnostic products for use in the diagnosis and management of patients with asthma, was part of i
Read more